Administrative subordination von Shah, Bijal

Volltext

Executive (agency) administration von Shah, Bijal

Volltext

UNCOVERING COORDINATED INTERAGENCY ADJUDICATION von Shah, Bijal

Volltext

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma von Logue, Jennifer M, Zucchetti, Elisa, Bachmeier, Christina A, Krivenko, Gabriel S, Larson, Victoria, Ninh, Daniel, Grillo, Giovanni, Cao, Biwei, Kim, Jongphil, Chavez, Julio C, Baluch, Aliyah, Khimani, Farhad, Lazaryan, Aleksandr, Nishihori, Taiga, Liu, Hien D, Pinilla-Ibarz, Javier, Shah, Bijal D, Faramand, Rawan, Coghill, Anna E, Davila, Marco L, Dholaria, Bhagirathbhai R, Jain, Michael D, Locke, Frederick L

Volltext

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study von Shah, Bijal D, Ghobadi, Armin, Oluwole, Olalekan O, Logan, Aaron C, Boissel, Nicolas, Cassaday, Ryan D, Leguay, Thibaut, Bishop, Michael R, Topp, Max S, Tzachanis, Dimitrios, O'Dwyer, Kristen M, Arellano, Martha L, Lin, Yi, Baer, Maria R, Schiller, Gary J, Park, Jae H, Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C, Wierda, William G, DeAngelo, Daniel J, Stiff, Patrick, Jeyakumar, Deepa, Feng, Chaoling, Dong, Jinghui, Shen, Tong, Milletti, Francesca, Rossi, John M, Vezan, Remus, Masouleh, Behzad Kharabi, Houot, Roch

Volltext

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) von Alvi, Raza M., Frigault, Matthew J., Fradley, Michael G., Jain, Michael D., Mahmood, Syed S., Awadalla, Magid, Lee, Dae Hyun, Zlotoff, Daniel A., Zhang, Lili, Drobni, Zsofia D., Hassan, Malek Z.O., Bassily, Emmanuel, Rhea, Isaac, Ismail-Khan, Roohi, Mulligan, Connor P., Banerji, Dahlia, Lazaryan, Aleksandr, Shah, Bijal D., Rokicki, Adam, Raje, Noopur, Chavez, Julio C., Abramson, Jeremy, Locke, Frederick L., Neilan, Tomas G.

Volltext

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external hist... von Shah, Bijal D, Ghobadi, Armin, Oluwole, Olalekan O, Logan, Aaron C, Boissel, Nicolas, Cassaday, Ryan D, Leguay, Thibaut, Bishop, Michael R, Topp, Max S, Tzachanis, Dimitrios, O'Dwyer, Kristen M, Arellano, Martha L, Lin, Yi, Baer, Maria R, Schiller, Gary J, Park, Jae H, Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique C, Wierda, William G, DeAngelo, Daniel J, Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra C, Faghmous, Imi, Masouleh, Behzad Kharabi, Houot, Roch

Volltext

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma von Sim, Austin J., Jain, Michael D., Figura, Nicholas B., Chavez, Julio C., Shah, Bijal D., Khimani, Farhad, Lazaryan, Aleksandr, Krivenko, Gabriel, Davila, Marco L., Liu, Hien D., Falchook, Aaron D., Dahiya, Saurabh, Rapoport, Aaron P., Kim, Sungjune, Locke, Frederick L., Robinson, Timothy J.

Volltext

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial von Wang, Michael, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Casasnovas, Olivier, Smith, Stephen D, Damaj, Gandhi, Doorduijn, Jeanette, Lamy, Thierry, Morschhauser, Franck, Panizo, Carlos, Shah, Bijal, Davies, Andrew, Eek, Richard, Dupuis, Jehan, Jacobsen, Eric, Kater, Arnon P, Le Gouill, Steven, Oberic, Lucie, Robak, Taduesz, Covey, Todd, Dua, Richa, Hamdy, Ahmed, Huang, Xin, Izumi, Raquel, Patel, Priti, Rothbaum, Wayne, Slatter, J Greg, Jurczak, Wojciech

Volltext

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma von Ruan, Jia, Martin, Peter, Shah, Bijal, Schuster, Stephen J, Smith, Sonali M, Furman, Richard R, Christos, Paul, Rodriguez, Amelyn, Svoboda, Jakub, Lewis, Jessica, Katz, Orel, Coleman, Morton, Leonard, John P

Volltext

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results von Shah, Bijal D., Bishop, Michael R., Oluwole, Olalekan O., Logan, Aaron C., Baer, Maria R., Donnellan, William B., O'Dwyer, Kristen M., Holmes, Houston, Arellano, Martha L., Ghobadi, Armin, Pagel, John M., Lin, Yi, Cassaday, Ryan D., Park, Jae H., Abedi, Mehrdad, Castro, Januario E., DeAngelo, Daniel J., Malone, Adriana K., Mawad, Raya, Schiller, Gary J., Rossi, John M., Bot, Adrian, Shen, Tong, Goyal, Lovely, Jain, Rajul K., Vezan, Remus, Wierda, William G.

Volltext

Dose fractionation of CAR-T cells. A systematic review of clinical outcomes von Frigault, Matthew, Rotte, Anand, Ansari, Ayub, Gliner, Bradford, Heery, Christopher, Shah, Bijal

Volltext

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models von Zhao, Xiaohong, Ren, Yuan, Lawlor, Matthew, Shah, Bijal D., Park, Paul M.C., Lwin, Tint, Wang, Xuefeng, Liu, Kenian, Wang, Michelle, Gao, Jing, Li, Tao, Xu, Mousheng, Silva, Ariosto S., Lee, Kaplan, Zhang, Tinghu, Koomen, John M., Jiang, Huijuan, Sudalagunta, Praneeth R., Meads, Mark B., Cheng, Fengdong, Bi, Chengfeng, Fu, Kai, Fan, Huitao, Dalton, William S., Moscinski, Lynn C., Shain, Kenneth H., Sotomayor, Eduardo M., Wang, Gang Greg, Gray, Nathanael S., Cleveland, John L., Qi, Jun, Tao, Jianguo

Volltext

Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition von Yu, Anan, Shibata, Yoko, Shah, Bijal, Calamini, Barbara, Lo, Donald C, Morimoto, Richard I

Volltext

Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prog... von Le Gouill, Steven, Długosz-Danecka, Monika, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Smith, Stephen D, Doorduijn, Jeanette K, Panizo, Carlos, Shah, Bijal D, Davies, Andrew J, Eek, Richard, Jacobsen, Eric, Kater, Arnon P, Robak, Tadeusz, Jain, Preetesh, Calvo, Roser, Tao, Lin, Wang, Michael

Volltext

Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma von Ruan, Jia, Martin, Peter, Christos, Paul, Cerchietti, Leandro, Tam, Wayne, Shah, Bijal, Schuster, Stephen J., Rodriguez, Amelyn, Hyman, David, Calvo-Vidal, Maria Nieves, Smith, Sonali M., Svoboda, Jakub, Furman, Richard R., Coleman, Morton, Leonard, John P.

Volltext

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma von Dean, Erin A., Mhaskar, Rahul S., Lu, Hong, Mousa, Mina S., Krivenko, Gabriel S., Lazaryan, Aleksandr, Bachmeier, Christina A., Chavez, Julio C., Nishihori, Taiga, Davila, Marco L., Khimani, Farhad, Liu, Hien D., Pinilla-Ibarz, Javier, Shah, Bijal D., Jain, Michael D., Balagurunathan, Yoganand, Locke, Frederick L.

Volltext

Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function von Watters, January M., Wright, Gabriela, Smith, Matthew A., Shah, Bijal, Wright, Kenneth L.

Volltext

Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas von Gao, Jing, Wang, Michelle Y, Ren, Yuan, Lwin, Tint, Li, Tao, Yan, Joy C, Sotomayor, Eduardo M, Duckett, Derek R, Shah, Bijal D, Shain, Kenneth H, Zhao, Xiaohong, Tao, Jianguo

Volltext

PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas von Ren, Yuan, Bi, Chengfeng, Zhao, Xiaohong, Lwin, Tint, Wang, Cheng, Yuan, Ji, Silva, Ariosto S, Shah, Bijal D, Fang, Bin, Li, Tao, Koomen, John M, Jiang, Huijuan, Chavez, Julio C, Pham, Lan V, Sudalagunta, Praneeth R, Wan, Lixin, Wang, Xuefeng, Dalton, William S, Moscinski, Lynn C, Shain, Kenneth H, Vose, Julie, Cleveland, John L, Sotomayor, Eduardo M, Fu, Kai, Tao, Jianguo

Volltext